A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)
Clinical trial NCT04964089 · COMPLETED
Trial details
- NCT number
- NCT04964089
- Sponsor
- Kodiak Sciences Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-23
- Primary completion
- 2023-03-28
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.